MDM2-NFAT1 dual inhibitor, MA242: Effective against hepatocellular carcinoma, independent of p53

出版年份 2019 全文链接

标题

作者

关键词

Hepatocellular carcinoma, MDM2, NFAT1, Metastasis, CRISPR/Cas9, Patient-derived xenograft

出版物

Volume 459, Issue -, Pages 156-167

出版商

Elsevier BV

发表日期

2019-06-08

DOI

10.1016/j.canlet.2019.114429

联系作者

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started